Literature DB >> 15008997

Insulin resistance and endothelial dysfunction in the brothers of Indian subcontinent Asian women with polycystic ovaries.

R Kaushal1, N Parchure, G Bano, J-C Kaski, S S Nussey.   

Abstract

BACKGROUND: Ultrasonographic appearances of polycystic ovaries (PCO) are found in 50% of South London Indian subcontinent Asians, a population at high risk of coronary disease and type 2 diabetes (DM). PCO is a familial condition but the genetics remain to be clarified. At present, the only characteristic documented in male family members is premature male pattern balding before the age of 30 years. Our aim was to quantify insulin resistance and endothelial cell function in the brothers of Indian subcontinent Asian women with PCO and/or a family history of type 2 DM.
METHODS: Indian subcontinent Asian women (n = 40, age 16-40 years) with a brother available for study were recruited from the local population. They were stratified into four groups according to the ultrasound appearances of PCO and/or a family history of type 2 DM. Control subjects had no PCO and no family history of DM. Insulin sensitivity (KITT) was measured using a short insulin tolerance test and endothelial function using brachial artery ultrasound to measure flow-mediated dilatation (FMD).
FINDINGS: Groups were well matched for age, body mass index (BMI) and waist-hip circumference ratios. Asian women with PCO demonstrated insulin resistance independent of BMI or family history of diabetes. Women with PCO and a family history of DM have reduced FMD, though PCO alone was not a marker. The brothers of women with PCO also have insulin resistance, comparable to that associated with a family history of type 2 DM. This was associated with elevations of blood pressure, abnormalities in serum lipid concentrations and impaired endothelial cell function. Endothelial cell function was particularly impaired in those subjects with both a sister with PCO and a family history of DM.
INTERPRETATION: In an ethnic minority population at higher risk of coronary heart disease, brothers of women with PCO have evidence of insulin resistance and endothelial cell dysfunction in early adult life. Further study is required to establish whether these findings are associated with an increased incidence of cardiovascular events in this population.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15008997     DOI: 10.1111/j.1365-2265.2004.01981.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  14 in total

Review 1.  The role of genes and environment in the etiology of PCOS.

Authors:  Evanthia Diamanti-Kandarakis; Helen Kandarakis; Richard S Legro
Journal:  Endocrine       Date:  2006-08       Impact factor: 3.633

Review 2.  Does a male polycystic ovarian syndrome equivalent exist?

Authors:  R Cannarella; R A Condorelli; L M Mongioì; S La Vignera; A E Calogero
Journal:  J Endocrinol Invest       Date:  2017-07-15       Impact factor: 4.256

Review 3.  Polycystic ovary syndrome: etiology, pathogenesis and diagnosis.

Authors:  Mark O Goodarzi; Daniel A Dumesic; Gregorio Chazenbalk; Ricardo Azziz
Journal:  Nat Rev Endocrinol       Date:  2011-01-25       Impact factor: 43.330

Review 4.  Cardiovascular complications of obesity in adolescents.

Authors:  F Orio; S Palomba; T Cascella; S Savastano; G Lombardi; A Colao
Journal:  J Endocrinol Invest       Date:  2007-01       Impact factor: 4.256

5.  Brothers of women with polycystic ovary syndrome are characterised by impaired glucose tolerance, reduced insulin sensitivity and related metabolic defects.

Authors:  J-P Baillargeon; A C Carpentier
Journal:  Diabetologia       Date:  2007-09-27       Impact factor: 10.122

6.  Evidence for pancreatic beta-cell dysfunction in brothers of women with polycystic ovary syndrome.

Authors:  Susan Sam; Yeon-Ah Sung; Richard S Legro; Andrea Dunaif
Journal:  Metabolism       Date:  2008-01       Impact factor: 8.694

Review 7.  Metabolic syndrome, hypertension, and hyperlipidemia in mothers, fathers, sisters, and brothers of women with polycystic ovary syndrome: a systematic review and meta-analysis.

Authors:  Bulent Yilmaz; Priyathama Vellanki; Baris Ata; Bulent Okan Yildiz
Journal:  Fertil Steril       Date:  2018-01-11       Impact factor: 7.329

Review 8.  [Metabolic and Reproductive Consequences of the Polycystic Ovary Syndrome (PCOS)].

Authors:  Michael Feichtinger; Tina Stopp; Christian Göbl
Journal:  Wien Med Wochenschr       Date:  2016-03

9.  State of the Art Review: Emerging Therapies: The Use of Insulin Sensitizers in the Treatment of Adolescents with Polycystic Ovary Syndrome (PCOS).

Authors:  David H Geller; Danièle Pacaud; Catherine M Gordon; Madhusmita Misra
Journal:  Int J Pediatr Endocrinol       Date:  2011-08-26

10.  Fetal androgen exposure is a determinant of adult male metabolic health.

Authors:  Katarzyna J Siemienowicz; Panagiotis Filis; Sophie Shaw; Alex Douglas; Jennifer Thomas; Sally Mulroy; Forbes Howie; Paul A Fowler; W Colin Duncan; Mick T Rae
Journal:  Sci Rep       Date:  2019-12-27       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.